[PMID 19110417] hepatocellular carcinoma in Chinese populations
- increased risk rs4646421 (OR 1.30, 95% CI 1.05-1.61)
- increased risk rs2198843 (OR 1.33, 95% CI 1.05-1.69)
- reduced risk rs4886605 (OR 0.70. 95% CI 0.52-0.94)
[PMID 18268125] Assessment of interactions between PAH exposure and genetic polymorphisms on PAH-DNA adducts in African American, Dominican, and Caucasian mothers and newborns.
[PMID 18632753] Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes.
[PMID 18691756] Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk.
[PMID 18798002] Coffee consumption, genetic susceptibility and bladder cancer risk.
[PMID 19479063] Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression.